Benito-Casado, Cristina
Durán-Mateos, Esther
Ferrer-Donato, Águeda
García, Gemma Barroso
Domínguez-Rubio, Raúl
Povedano, Mónica
Fernandez-Martos, Carmen M.
Funding for this research was provided by:
“la Caixa” Banking Foundation and co-funded by Fundación Luzón (LCF/PR/HR19/52160016)
Article History
Received: 26 June 2025
Accepted: 15 September 2025
First Online: 9 October 2025
Declarations
:
: All animal procedures were performed in accordance with the Animal Ethics Committee of the Hospital Nacional de Parapléjicos (Approval No 36OH/2019) (Spain) in accordance with the European Communities Council Directive (86/609/EEC) for the Care and Use of Animals for Scientific Purposes. Human samples described in this manuscript were collected under protocols that were reviewed and approved by the Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, Hospitalet de Llobregat, (Spain). Subjects underwent informed consent prior to participating in research studies.
: All authors have read and agreed to the published version of the manuscript.
: The authors declare no competing interests.